Funderama
Welcome,         Profile    Billing    Logout  
 2 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
soto, jaime
NCT04799236: Treatment of Mucosal Bolivian Leishmaniasis

Recruiting
3
120
RoW
Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal amphotericin B
Fundacion Nacional de Dermatologia, Hospital Dermatologico de Jorochito, Centro Nacional de Enfermedades Tropicales CENETROP, ABF Foundation for Medical Research
Mucosal Leishmaniasis
04/24
11/24
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
soto, jaime
NCT04799236: Treatment of Mucosal Bolivian Leishmaniasis

Recruiting
3
120
RoW
Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal amphotericin B
Fundacion Nacional de Dermatologia, Hospital Dermatologico de Jorochito, Centro Nacional de Enfermedades Tropicales CENETROP, ABF Foundation for Medical Research
Mucosal Leishmaniasis
04/24
11/24
NCT04515186: Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Active, not recruiting
3
184
RoW
Meglumine Antimoniate, Glucantime®, Miltefosine, Impavido®, Thermotherapy machine, ThermoMed™
Drugs for Neglected Diseases
Cutaneous Leishmaniases
11/23
02/24

Download Options